Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Topics to be discussed
- Introduction to the microbiome
- Skin microbiome complexity
- Factors affecting the microbiome
- Beneficial effects of the microbiome
- Methods to study the microbiome
- Simplified model of the microbiome in action
- Effects of an altered microbiome
- Specific examples: cause vs. effect?
- The altered microbiome and cancer
- Manipulating the microbiome
- Utilizing probiotics for healthy outcomes
- Probiotics and prebiotics: our research
- Example: Akkermansia muciniphilia
- Fecal microbial transplantation (FMT)
- Big success in C.difficile infection
- Trends and future directions
- Microbiome research translation: challenges
- Conclusions
- Thank you
Topics Covered
- Introduction to microbiome
- Phyla, distribution and factors affecting microbiome
- Beneficial effects of microbiome to human health
- Manipulating the microbiome
- Microbiome therapy
- Challenges and future directions
Links
Series:
Categories:
Talk Citation
Eri, R. (2020, September 30). Translating microbiome research to clinics: trends, directions and challenges [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/YZTV5750.Export Citation (RIS)
Publication History
Financial Disclosures
- Raj Eri has no commercial/financial relationships to disclose.
Other Talks in the Series: Periodic Reports: Advances in Clinical Interventions and Research Platforms
Transcript
Please wait while the transcript is being prepared...
0:00
Hello, my name is Raj Eri.
I'm an Associate Professor based at the School of Health Sciences,
University of Tasmania in Australia.
I work on gut terminology and gut related diseases and microbiome.
This lecture is about microbiome research.
As we all know,
this is one of the most exciting areas of research.
Today's lecture will focus on how we can translate
these microbiome research into clinics where the commissions get in place.
Through this lecture, I'll also be talking about the trends.
What are the latest directions?
Of course, what are the challenges facing this particular research?
0:42
In this particular lecture,
the following topics will be discussed.
Initially, I'll be introducing to what constitutes the microbiome and
what are the various types of
microbiome and what are the factors that affect the microbiome.
In fact, we'll be covering next about the beneficial effects of
microbiome in human health and then we'll move on to show
some specific examples of how these microbiome could be translated to
clinics with a special emphasis on fecal microbiota transplantation.
The final part of the talk we'll look into the challenges and
future directions in microbiome research translation.
1:27
Microbiome, or microbiota, are the commonly used terms in research in this area.
Microbiota usually refers to the collective of all organisms.
For example bacteria, viruses, fungi, archaea.
These are the common organisms that are present within our bodies,
and that's what is collectively called as microbiota.
If you include the genomes of all organisms,
then it is called as a microbiome.
These microbiota, these are present everywhere in
all our tissues and a typical healthy person of about 70 kilograms,
about three percent or 2.2 kilograms constitute the microbiota.
Usually they say the datas by 10-1 and in terms of genomes,
it's even more about 300-1 with respect to the microbial genome.
With respect to metabolism,
it is amazing that the metabolism
initiated or held by the microbiome is equal to that of liver.
We all know that liver does hundreds of functions, including metabolic functions.
It is just amazing to think how much they do to our system.
No wonder this field is exploding and
more importance is given to this field in terms of health and disease.
Within the human system,
the distributions diverse within the different sites in the human body.
In terms of phyla,
the majority of phyla belong to about 10,
but the diversity in different sites for example,
one of the microbiome, skin and vaginal or fecal microbiome is so explosive.
The diversity of the microbiota is at different sites of the body.
Hide